Charles River Laboratories International, Inc.CRLNYSE
Loading
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 2,924 | 3,540↑21.1% | 3,976↑12.3% | 4,129↑3.9% | 4,050↓1.9% |
| Gross Profit | 1,074 | 1,335↑24.3% | 1,463↑9.6% | 1,503↑2.7% | 1,332↓11.4% |
| Operating Income | 433 | 590↑36.3% | 651↑10.4% | 617↓5.2% | 227↓63.2% |
| Net Income | 364 | 391↑7.3% | 486↑24.4% | 475↓2.4% | 10↓97.8% |
| EBITDA | 768 | 820↑6.7% | 986↑20.2% | 1,032↑4.7% | 581↓43.7% |
| EPS Diluted | 7.20 | 7.60↑5.6% | 9.48↑24.7% | 9.22↓2.7% | 0.20↓97.8% |